Katharina Auer

发表

Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues

R. Zeillinger, I. Mesteri, D. Pils, 2015, Scientific Reports.

Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer

L. Kenner, C. Grimm, D. Pils, 2017, Scientific Reports.

Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.

Ignace Vergote, Jalid Sehouli, Ioana Braicu, 2014, European journal of cancer.

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium

C. Denkert, R. Zeillinger, I. Vergote, 2014, Molecular Cancer.

Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?

R. Horvat, D. Pils, Anna Bachmayr-Heyda, 2017, Cold Spring Harbor molecular case studies.

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome

R. Zeillinger, R. Horvat, C. Grimm, 2015, Oncotarget.

Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling

Z. Giricz, P. Ferdinandy, S. Hoerstrup, 2017, Scientific Reports.

Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.

D. Pils, Anna Bachmayr-Heyda, Katharina Auer, 2017, Cancer letters.

Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread

S. Polterauer, D. Pils, Anna Bachmayr-Heyda, 2016, Oncotarget.

Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer

K. Schmetterer, R. Horvat, C. Grimm, 2016, Oncotarget.

Characterization of cell populations in ascites of ovarian cancer patients

Katharina Auer, 2013 .

Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer

K. Schmetterer, D. Pils, Anna Bachmayr-Heyda, 2016, Clinical Cancer Research.

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium

C. Denkert, R. Zeillinger, I. Vergote, 2014, Molecular Cancer.

EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs

Sai Kiang Lim, Dietmar Pils, R. Zeillinger, 2017, Disease markers.

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome

R. Zeillinger, R. Horvat, C. Grimm, 2015, Oncotarget.